1. Home
  2. TEVA
  3. TEVA News

Latest Teva Pharmaceutical Industries Limited (TEVA) News on January 22, 2025

Ozempic, Xtandi among next 15 drugs selected for U.S. price talks
TEVA

TipRanks

4 days ago

Ozempic, Xtandi among next 15 drugs selected for U.S. price talks

TEVA

MT Newswires

4 days ago

Update: Novo Nordisk's Ozempic, Wegovy Among Drugs Chosen for US Medicare Price Talks

Novo Nordisk's stock down 4% as the Feds get ready for a second round of drug price negotiations
TEVA

Yahoo Finance

5 days ago

Novo Nordisk's stock down 4% as the Feds get ready for a second round of drug price negotiations

How Teva Pharmaceuticals is thinking about Trump's return: CEO
TEVA

Yahoo Finance Video

9 days ago

How Teva Pharmaceuticals is thinking about Trump's return: CEO

Amicus Posts Preliminary 2024 Results, Issues 2025 Outlook
TEVA

Zacks

9 days ago

Amicus Posts Preliminary 2024 Results, Issues 2025 Outlook

TEVA

MT Newswires

9 days ago

Teva Pharmaceuticals International Enters Collaboration to Commercialize Eye Disease Treatment

Teva Announces Collaboration to Commercialize Formycon’s Biosimilar Candidate to Eylea® (aflibercept) in major parts of Europe and in Israel
TEVA

GlobeNewswire

9 days ago

Teva Announces Collaboration to Commercialize Formycon’s Biosimilar Candidate to Eylea® (aflibercept) in major parts of Europe and in Israel

TEVA

MT Newswires

12 days ago

Teva Pharmaceutical, Samsung Bioepis to Commercialize Epysqli in US

Samsung Bioepis and Teva Enter into a Strategic Partnership for Commercialization of EPYSQLI® (eculizumab-aagh) in the United States
TEVA

GlobeNewswire

12 days ago

Samsung Bioepis and Teva Enter into a Strategic Partnership for Commercialization of EPYSQLI® (eculizumab-aagh) in the United States

Biotech Stock Roundup: NMRA Plunges on Study Failure, HOTH, VIR Soar on Study Data & More
TEVA

Zacks

13 days ago

Biotech Stock Roundup: NMRA Plunges on Study Failure, HOTH, VIR Soar on Study Data & More

Catalyst Pharmaceuticals Settles Patent Litigation Case With Teva Pharmaceutical
TEVA

Benzinga

13 days ago

Catalyst Pharmaceuticals Settles Patent Litigation Case With Teva Pharmaceutical

CPRX Stock Rises 17% on Settling Firdapse Patent Litigation With Teva
TEVA

Zacks

13 days ago

CPRX Stock Rises 17% on Settling Firdapse Patent Litigation With Teva

IBD Tech Leader Catalyst Rockets After Striking A Key Deal With Teva
TEVA

Investor's Business Daily

13 days ago

IBD Tech Leader Catalyst Rockets After Striking A Key Deal With Teva

TEVA

MT Newswires

13 days ago

Sector Update: Health Care Stocks Advance Late Afternoon

TEVA

MT Newswires

13 days ago

Sector Update: Health Care Stocks Higher in Afternoon Trading

Why Teva Pharmaceuticals Industries Ltd. (TEVA) Crashed Yesterday
TEVA

Insider Monkey

19 days ago

Why Teva Pharmaceuticals Industries Ltd. (TEVA) Crashed Yesterday

TEVA

Argus Research

23 days ago

Weekly Stock List

Teva Pharmaceutical Industries Ltd (TEVA) Ends Trading Week Defying Market Bloodbath
TEVA

Insider Monkey

25 days ago

Teva Pharmaceutical Industries Ltd (TEVA) Ends Trading Week Defying Market Bloodbath

TEVA

MT Newswires

a month ago

Teva Pharmaceutical Industries Insider Sold Shares Worth $6,294,031, According to a Recent SEC Filing

Billionaire Stanley Druckenmiller Is Selling Nvidia and Palantir and Piling Into One of Wall Street's Hottest Drug Stocks Ahead of 2025
TEVA

Motley Fool

a month ago

Billionaire Stanley Druckenmiller Is Selling Nvidia and Palantir and Piling Into One of Wall Street's Hottest Drug Stocks Ahead of 2025

Why Teva Pharmaceuticals Industries (TEVA) Skyrocketed?
TEVA

Insider Monkey

a month ago

Why Teva Pharmaceuticals Industries (TEVA) Skyrocketed?

Teva to Present at the 43rd Annual J.P. Morgan Healthcare Conference
TEVA

GlobeNewswire

a month ago

Teva to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory
TEVA

Insider Monkey

a month ago

Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory

Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results and 2025 Financial Guidance at 8 a.m. ET on January 29, 2025
TEVA

GlobeNewswire

a month ago

Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results and 2025 Financial Guidance at 8 a.m. ET on January 29, 2025

Pharma Stock Roundup: PFE's 2025 Outlook, MRK & ABBV's M&A Deals
TEVA

Zacks

a month ago

Pharma Stock Roundup: PFE's 2025 Outlook, MRK & ABBV's M&A Deals

My Top 10 Portfolio Holdings for 2025
TEVA

Motley Fool

a month ago

My Top 10 Portfolio Holdings for 2025

Teva price target raised to $28 from $26 at UBS
TEVA

TipRanks

a month ago

Teva price target raised to $28 from $26 at UBS

Jim Cramer on Teva Pharmaceutical Industries (TEVA): A Game-Changer for Intractable Disease Treatments?
TEVA

Insider Monkey

a month ago

Jim Cramer on Teva Pharmaceutical Industries (TEVA): A Game-Changer for Intractable Disease Treatments?

TEVA

MT Newswires

a month ago

Teva Pharmaceutical Stock Positioned for Even Better Performance in 2025, UBS Says

TEVA

MT Newswires

a month ago

BofA Securities Raises Price Target on Teva Pharmaceutical Industries to $25 From $23, Keeps Buy Rating

SNY, TEVA Stocks Jump on Encouraging Data From IBD Drug Study
TEVA

Zacks

a month ago

SNY, TEVA Stocks Jump on Encouraging Data From IBD Drug Study

Fed decision looms, Nvidia looks to rebound: Yahoo Finance
TEVA

Yahoo Finance Video

a month ago

Fed decision looms, Nvidia looks to rebound: Yahoo Finance

Strength Seen in Teva Pharmaceutical Industries (TEVA): Can Its 26.5% Jump Turn into More Strength?
TEVA

Zacks

a month ago

Strength Seen in Teva Pharmaceutical Industries (TEVA): Can Its 26.5% Jump Turn into More Strength?

Sanofi and Teva’s duvakitug meets primary endpoints in Phase IIb trial
TEVA

Clinical Trials Arena

a month ago

Sanofi and Teva’s duvakitug meets primary endpoints in Phase IIb trial

TEVA

Morningstar Research

a month ago

Analyst Report: Teva Pharmaceutical Industries Limited

Teva and Sanofi jump on experimental bowel disease drug success
TEVA

Yahoo Finance Video

a month ago

Teva and Sanofi jump on experimental bowel disease drug success

Teva Catapults 26%, Hitting A Six-Year High, After Scoring A Win With Sanofi-Tied Drug
TEVA

Investor's Business Daily

a month ago

Teva Catapults 26%, Hitting A Six-Year High, After Scoring A Win With Sanofi-Tied Drug

Teva, Sanofi Say Inflammatory Bowel Disease Drug Study Meets Primary Endpoints
TEVA

MT Newswires

a month ago

Teva, Sanofi Say Inflammatory Bowel Disease Drug Study Meets Primary Endpoints

Positive Test Results Reported for Teva-Sanofi Drug for Ulcerative Colitis, Crohn's
TEVA

Investopedia

a month ago

Positive Test Results Reported for Teva-Sanofi Drug for Ulcerative Colitis, Crohn's

TEVA

MT Newswires

a month ago

Update: Teva, Sanofi Shares Jump as Phase 2B Duvakitug Study Meets Primary Endpoints in Inflammatory Bowel Disease

Teva Stock Soars 19% as Game-Changing IBD Drug Duvakitug Crushes Trial Expectations
TEVA

GuruFocus.com

a month ago

Teva Stock Soars 19% as Game-Changing IBD Drug Duvakitug Crushes Trial Expectations

Teva, Cloudflare, Sanofi: Trending Tickers
TEVA

Yahoo Finance Video

a month ago

Teva, Cloudflare, Sanofi: Trending Tickers

Teva Soars, Sanofi Gains on Strong Trial Results for IBD Treatment
TEVA

The Wall Street Journal

a month ago

Teva Soars, Sanofi Gains on Strong Trial Results for IBD Treatment

Teva Catapults 20%, Nearing A Five-Year High, After Scoring A Win With Sanofi-Tied Drug
TEVA

Investor's Business Daily

a month ago

Teva Catapults 20%, Nearing A Five-Year High, After Scoring A Win With Sanofi-Tied Drug

Teva Shares Soar on Early Bowel Disease Drug Data
TEVA

Barrons.com

a month ago

Teva Shares Soar on Early Bowel Disease Drug Data

Why Are Teva And Sanofi Stocks Trading Higher On Tuesday?
TEVA

Benzinga

a month ago

Why Are Teva And Sanofi Stocks Trading Higher On Tuesday?

TEVA

MT Newswires

a month ago

Teva, Sanofi Say Phase 2B Duvakitug Study Meets Primary Endpoints in Inflammatory Bowel Disease

Teva and Sanofi Announce Duvakitug (Anti-TL1A) Positive Phase 2b Results Demonstrating Best-in-Class Potential in Ulcerative Colitis and Crohn’s Disease
TEVA

GlobeNewswire

a month ago

Teva and Sanofi Announce Duvakitug (Anti-TL1A) Positive Phase 2b Results Demonstrating Best-in-Class Potential in Ulcerative Colitis and Crohn’s Disease

Teva Announces New Patient Access Program with Direct Relief to Provide Access to Inhalers for Uninsured Patients
TEVA

GlobeNewswire

a month ago

Teva Announces New Patient Access Program with Direct Relief to Provide Access to Inhalers for Uninsured Patients

TEVA

MT Newswires

2 months ago

Teva Pharmaceutical to Divest Japanese Venture to JKI

Teva Announces Agreement to Divest Teva-Takeda, its Business Venture in Japan
TEVA

GlobeNewswire

2 months ago

Teva Announces Agreement to Divest Teva-Takeda, its Business Venture in Japan

Teva reports positive outcomes from episodic migraine trial in young patients
TEVA

Clinical Trials Arena

2 months ago

Teva reports positive outcomes from episodic migraine trial in young patients

TEVA

MT Newswires

2 months ago

Teva Pharmaceutical Says Migraine Prevention Drug Shows Efficacy in Younger Patients

Teva Presents Positive Efficacy and Safety Data of AJOVY® (fremanezumab) for the Prevention of Episodic Migraine in Children and Adolescents from Phase 3 SPACE Trial
TEVA

GlobeNewswire

2 months ago

Teva Presents Positive Efficacy and Safety Data of AJOVY® (fremanezumab) for the Prevention of Episodic Migraine in Children and Adolescents from Phase 3 SPACE Trial

TEVA Stock Down 10% in a Month: Should You Buy the Dip?
TEVA

Zacks

2 months ago

TEVA Stock Down 10% in a Month: Should You Buy the Dip?

Teva to Present at the 7th Annual Evercore ISI HealthCONx Conference
TEVA

GlobeNewswire

2 months ago

Teva to Present at the 7th Annual Evercore ISI HealthCONx Conference

Teva Pharmaceutical (TEVA): The Global Leader in Affordable Medicine Under $25
TEVA

Insider Monkey

2 months ago

Teva Pharmaceutical (TEVA): The Global Leader in Affordable Medicine Under $25

TEVA

Argus Research

2 months ago

Weekly Stock List

Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory
TEVA

Insider Monkey

2 months ago

Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory

TEVA

Argus Research

2 months ago

Analyst Report: Teva Phar Inds Lt

TEVA

Argus Research

2 months ago

Market Update: CP, TEVA, MET, IGT

Teva to Present at the Jefferies London Healthcare Conference
TEVA

GlobeNewswire

2 months ago

Teva to Present at the Jefferies London Healthcare Conference

Are Investors Undervaluing Teva Pharmaceutical Industries (TEVA) Right Now?
TEVA

Zacks

2 months ago

Are Investors Undervaluing Teva Pharmaceutical Industries (TEVA) Right Now?

Amicus' Q3 Earnings & Revenues Beat Estimates, '24 View Updated
TEVA

Zacks

2 months ago

Amicus' Q3 Earnings & Revenues Beat Estimates, '24 View Updated

TEVA Stock Down 7% Despite Q3 Earnings & Sales Beat, Guidance Increase
TEVA

Zacks

2 months ago

TEVA Stock Down 7% Despite Q3 Earnings & Sales Beat, Guidance Increase

Teva Pharmaceutical Industries Ltd (TEVA) Q3 2024 Earnings Call Highlights: Strong Revenue ...
TEVA

GuruFocus.com

2 months ago

Teva Pharmaceutical Industries Ltd (TEVA) Q3 2024 Earnings Call Highlights: Strong Revenue ...

'This Is A New Teva,' Says CEO. But Investors Don't Seem To Believe.
TEVA

Investor's Business Daily

2 months ago

'This Is A New Teva,' Says CEO. But Investors Don't Seem To Believe.

TEVA

Morningstar Research

2 months ago

Analyst Report: Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries (TEVA) Q3 2024 Earnings Call Transcript
TEVA

Motley Fool

3 months ago

Teva Pharmaceutical Industries (TEVA) Q3 2024 Earnings Call Transcript

Teva's Explosive Q3 Results: Pivot to Growth Strategy Shocks Investors with Record Revenue Surge
TEVA

GuruFocus.com

3 months ago

Teva's Explosive Q3 Results: Pivot to Growth Strategy Shocks Investors with Record Revenue Surge

Teva Pharmaceutical Industries (TEVA) Reports Q3 Earnings: What Key Metrics Have to Say
TEVA

Zacks

3 months ago

Teva Pharmaceutical Industries (TEVA) Reports Q3 Earnings: What Key Metrics Have to Say

Teva Pharmaceutical Flashes A Buy Signal On Upbeat Third-Quarter Report
TEVA

Investor's Business Daily

3 months ago

Teva Pharmaceutical Flashes A Buy Signal On Upbeat Third-Quarter Report

TEVA

MT Newswires

3 months ago

Teva Pharmaceutical Q3 Non-GAAP Earnings, Net Revenue Rise; 2024 Outlook Updated

Teva Announces Strong Financial Results for the Third Quarter of 2024, led by Generics Performance and Innovative Portfolio Growth; Raises 2024 Financial Outlook including on Revenues, Adjusted EBITDA and Non-GAAP EPS
TEVA

GlobeNewswire

3 months ago

Teva Announces Strong Financial Results for the Third Quarter of 2024, led by Generics Performance and Innovative Portfolio Growth; Raises 2024 Financial Outlook including on Revenues, Adjusted EBITDA and Non-GAAP EPS

What's in Store for These 5 Drug & Biotech Stocks in Q3 Earnings?
TEVA

Zacks

3 months ago

What's in Store for These 5 Drug & Biotech Stocks in Q3 Earnings?

Teva Pharmaceutical Industries (TEVA) Upgraded to Strong Buy: What Does It Mean for the Stock?
TEVA

Zacks

3 months ago

Teva Pharmaceutical Industries (TEVA) Upgraded to Strong Buy: What Does It Mean for the Stock?

TEVA

MT Newswires

3 months ago

Teva Pharmaceuticals Schizophrenia Drug Delivery Trial Shows Improvement in Social Functioning

Teva Presents New Tardive Dyskinesia Data at Psych Congress 2024 from the IMPACT-TD Registry, Revealing Differences in Patient Experience Based on Underlying Psychiatric Condition
TEVA

GlobeNewswire

3 months ago

Teva Presents New Tardive Dyskinesia Data at Psych Congress 2024 from the IMPACT-TD Registry, Revealing Differences in Patient Experience Based on Underlying Psychiatric Condition

Teva Presents Latest Schizophrenia Treatment Research, Including Phase 3 SOLARIS Trial Results Demonstrating Improvements in Social Functioning and Quality of Life in Adults Receiving TEV-'749 (olanzapine) a Subcutaneous Long-Acting Injectable as well as Results of Real-World Analyses of UZEDY® (risperidone)
TEVA

GlobeNewswire

3 months ago

Teva Presents Latest Schizophrenia Treatment Research, Including Phase 3 SOLARIS Trial Results Demonstrating Improvements in Social Functioning and Quality of Life in Adults Receiving TEV-'749 (olanzapine) a Subcutaneous Long-Acting Injectable as well as Results of Real-World Analyses of UZEDY® (risperidone)

Countdown to Teva Pharmaceutical Industries (TEVA) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
TEVA

Zacks

3 months ago

Countdown to Teva Pharmaceutical Industries (TEVA) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS

EC fines Teva $502m over multiple sclerosis treatment Copaxone practices
TEVA

Pharmaceutical Technology

3 months ago

EC fines Teva $502m over multiple sclerosis treatment Copaxone practices

TEVA

Morningstar Research

3 months ago

Analyst Report: Teva Pharmaceutical Industries Limited

EU Commission fines Teva $500 million for trying to stop rival's multiple sclerosis drug
TEVA

Associated Press Finance

3 months ago

EU Commission fines Teva $500 million for trying to stop rival's multiple sclerosis drug

TEVA

MT Newswires

3 months ago

Update: European Commission Fines Teva $502.8 Million

TEVA

MT Newswires

3 months ago

European Commission Fines Teva $502.8 Million

Teva Fined Around $500 Million by EU Over MS Drug Competition Concerns
TEVA

The Wall Street Journal

3 months ago

Teva Fined Around $500 Million by EU Over MS Drug Competition Concerns

Teva Statement on European Commission Decision; Company to Appeal
TEVA

GlobeNewswire

3 months ago

Teva Statement on European Commission Decision; Company to Appeal

Investors in Teva Pharmaceutical Industries (NYSE:TEVA) have seen impressive returns of 120% over the past year
TEVA

Simply Wall St.

3 months ago

Investors in Teva Pharmaceutical Industries (NYSE:TEVA) have seen impressive returns of 120% over the past year

Wall Street Analysts Predict a 25.1% Upside in Teva Pharmaceutical Industries (TEVA): Here's What You Should Know
TEVA

Zacks

3 months ago

Wall Street Analysts Predict a 25.1% Upside in Teva Pharmaceutical Industries (TEVA): Here's What You Should Know

Biotech Stock Roundup: FOLD Settles Patent Dispute, Updates From EDIT & More
TEVA

Zacks

3 months ago

Biotech Stock Roundup: FOLD Settles Patent Dispute, Updates From EDIT & More

Should Value Investors Buy Teva Pharmaceutical Industries (TEVA) Stock?
TEVA

Zacks

3 months ago

Should Value Investors Buy Teva Pharmaceutical Industries (TEVA) Stock?

Are Medical Stocks Lagging Teva Pharmaceutical Industries (TEVA) This Year?
TEVA

Zacks

3 months ago

Are Medical Stocks Lagging Teva Pharmaceutical Industries (TEVA) This Year?

Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory
TEVA

Insider Monkey

3 months ago

Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory

TEVA

MT Newswires

3 months ago

Alvotech, Teva's Stelara Biosimilar Gets FDA Approval for New IV Presentation

Alvotech and Teva Announce U.S. FDA Approval of Additional Presentation of SELARSDI™ (ustekinumab-aekn), Expanding its Label to Include Further Indications Approved for Reference Product, Stelara® (ustekinumab)
TEVA

GlobeNewswire

3 months ago

Alvotech and Teva Announce U.S. FDA Approval of Additional Presentation of SELARSDI™ (ustekinumab-aekn), Expanding its Label to Include Further Indications Approved for Reference Product, Stelara® (ustekinumab)

FOLD Stock Rises on Settling Galafold Patent Dispute With Teva
TEVA

Zacks

3 months ago

FOLD Stock Rises on Settling Galafold Patent Dispute With Teva

Amicus Therapeutics (FOLD) Stock Jumps 14.0%: Will It Continue to Soar?
TEVA

Zacks

3 months ago

Amicus Therapeutics (FOLD) Stock Jumps 14.0%: Will It Continue to Soar?

TEVA

MT Newswires

3 months ago

Update: Amicus Therapeutics Shares Surge After Settling Patent Suit Against Teva Pharmaceuticals With License Deal

Amicus Therapeutics Settles Patent Lawsuit Teva Pharmaceuticals Over Generic Version Of Its Rare Genetic Disorder Drug
TEVA

Benzinga

3 months ago

Amicus Therapeutics Settles Patent Lawsuit Teva Pharmaceuticals Over Generic Version Of Its Rare Genetic Disorder Drug

TEVA

MT Newswires

3 months ago

Amicus Therapeutics Settles Patent Suit Against Teva Pharmaceuticals with License Agreement

Share on Social Networks: